Email not displaying correctly?  View it in your browser.
Volume 5, Issue 1, March 2016

Director's message: Colorectal cancer awareness month
New DNA stool test makes colorectal cancer screening easier for patients.
Liquid biopsy tracks cancer
A liquid biopsy may help determine treatment options as cancer evolves.
Pill use associated with better ovarian cancer outcomes
Research findings may drive new therapeutic targets for patients with ovarian cancer.
Surgery an option for more patients with pancreatic cancer
Complex tumor removal operations may increase survival in pancreatic cancer.
Stool DNA test good option for cancer screening in remote areas
The colorectal cancer test may offer more effective prevention and control for Alaska Native people.
Mayo Clinic, St. Vincent's collaborate on cancer services
Medical oncology and chemotherapy services will be offered in a new Florida medical suite.
Race may be a factor in colon cancer recurrence
Black people under 50 have more than double the risk of cancer recurrence compared with whites.
Protein may predict response to immunotherapy for melanoma
The discovery of biomarkers of sensitivity to treatment is vital for informing clinical decisions.
Meet the Investigator: Minetta C. Liu, M.D.
Dr. Liu's research focuses on breast cancer and blood-based biomarkers.
We're interested in your feedback about this email.

Want the Print Edition?
A print edition of Forefront is published annually. To request a free subscription, send your name and mailing address to
Mayo Clinic Cancer Center
5777 East Mayo Boulevard
Phoenix, AZ 85054

4500 San Pablo Road
Jacksonville, FL 32224

200 First Street SW
Rochester, MN 55905
Follow us:   
© 2016 Mayo Foundation for Medical Education and Research
200 First Street SW, Rochester, MN 55905
Terms of Use